Nanotechnology is defined as the use of materials with at least one dimension less than 100 nm. Although nanotechnology has revolutionized many fields to date, it use in medical applications remains at it infancy. This manuscript describes recent promising studies made towards increasing tissue regeneration through the use of nano compared to conventional materials.
Introduction
Nanomaterials can be broadly defined as the use materials whose components exhibit significantly changed properties when control is gained at the atomic, molecular, and supramolecular levels [1] . Although various definitions are attached to the word "nanomaterial" by different experts, the commonly accepted concept refers nanomaterials as that material with the basic structural unit in the range 1-100 nm (nanostructured), crystalline solids with grain sizes 1-100 nm (nanocrystals), individual layers or multilayer surface coatings in the range 1-100 nm (nanocoatings), extremely fine powders with an average particle size in the range 1-100 nm (nanopowders) and, fibers with a diameter in the range 1-100 nm (nanofibers). Nanostructure science and technology create materials and products that potentially outperform, at several boundaries, existing materials [1] . Assisted by these developments emerges, concurrently, nanotechnology, an endeavor able to work at the molecular level, atom by atom, to create large structures with fundamentally new molecular organizations.
Advances in several critical research fields (such as for processing, catalytic, optical, actuation, electrical, mechanical, etc.) have begun to benefit from new technological advancements in the area of nanotechnology [1] .
However, to date, relatively few advantages have been elucidated for biological applications (specifically, concerning cell interactions important for implants and/or tissue engineering applications). This review article seeks to demonstrate the promise that nanophase materials have to improve biological applications pertinent for orthopedics.
Rationale
There are many reasons to consider nanobiomaterials for orthopedic applications. For example, all living systems are governed by molecular behavior at nanometer scales. The molecular building blocks of life -proteins, nucleic acids, lipids, and carbohydrates -are examples of materials that possess unique properties determined by the size, folding, and patterns at the nanoscale. Bone is composed of proteins (for example, collagen) that possess nanometer features. In addition, other inorganic constituents in natural bone such as hydroxyapatite fibers possess dimensions between 2-5 nm in width, and lengths around 50 nm [2] . For this reason, cells in our body are accustomed to interacting with nanostructured surfaces, yet currently implanted bone materials are composed of micron grain sizes and topographies lacking nanofeatures [2] . In this manner, nanophase biomaterials seek to mimic the nano-topography of our natural tissues.
On a more scientific note, nanomaterials possess increased defects at their surfaces, higher surface areas, larger percentage of atoms at the surface compared to bulk, and greater electron delocalizations [3] ; all which contribute to unique surface energetics capable of altering initial protein interactions important for subsequent cell adhesion and tissue regeneration. Nanobiomaterials have been tested both in vitro and in vivo for their ability to promote bone regeneration.
Developments

Experimental Evidence of Increased Bone Regeneration on Nanophase Materials
Ceramics
The first reports correlating increased bone cell function with decreased ceramic grain sizes date back to 1998 [4] . Specifically, compared to conventional (micron grain size) ceramic formulations, ceramics made separately from spherical nanometer particles of alumina, titania, and hydroxyapatite enhanced in vitro adhesion of osteoblasts (bone-forming cells) while at the same time decreased adhesion of fibroblasts (cells that contribute to fibrous encapsulation and callus formation events that may lead to orthopedic implant loosening and failure). Equally as interesting, increased osteoblast functions appeared at ceramic spherical grain sizes (or consequently, surface spherical bumps) below 60 nm [5] . Thus, evidence was provided that the ability of nanophase ceramics to promote bone cell function was indeed limited to below 100 nm. Ceramics below this same grain size have been noted by others to possess special mechanical, catalytic, etc. properties [1] .
Studies further reported enhanced in vitro calcium deposition (calcium deposition is an index of mineralization of the bone matrix) by osteoblasts as well as increased functions of osteoclasts (bone-resorbing cells) on nanophase ceramics [6, 7] . Specifically, deposition of calcium by osteoblasts on nanophase alumina and titania was four and three times greater than on respective conventional ceramic formulations, respectively. Osteoclast synthesis of tartrate-resistant acid phosphatase (TRAP) and subsequent formation of resorption pits were three and two times greater on nanophase compared to conventional ceramics, respectively. Coordinated functions of osteoblasts and osteoclasts are imperative for the formation and maintenance of healthy new bone juxtaposed to an orthopedic implant. Frequently, newly formed bone juxtaposed to implants is not remodeled by osteoclasts and, thus, becomes unhealthy or necrotic [2] .
In fact, a recent report has indicated that the previously mentioned promising in vitro data translates in vivo (Figs. 1 and 2). In that study [8] , tantalum porous scaffolds were coated with nanometer and conventional hydroxyapatite particles. Compared to scaffolds coated with conventional grain size hydroxyapatite, results demonstrated significantly greater in vivo osseointegration of porous tantalum coated with nanophase hydroxyapatite after six weeks of implantation into rat calvaria. 
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Another design parameter to consider for orthopedic nanomaterials is particle aspect ratio. Specifically, consolidated substrates formulated from nanofibrous alumina (diameter: 2 nm, length > 50 nm) demonstrated significantly increased in vitro osteoblast functions in comparison with similar alumina substrates formulated from nanospherical particles [9] . Thus, perhaps not only is the grain size of bone important to mimic in nanophase ceramics, but its fibrous aspect ratio may also be important to emulate in synthetic materials.
Recently in vitro studies have also demonstrated decreased bacteria functions on nanophase ceramics (specifically, ZnO) [10] . Specifically, Staph. Epidermis (a bacteria well known to infect orthopedic implants surfaces [2] ) adhesion and colonization of orthopedic implant surfaces containing nanophase ZnO was significantly less than on those containing conventional ZnO. Compared to conventional ZnO, the authors speculated that decreased Staph. Epidermis function on nanophase ZnO occurred due to greater surface area and dissolution of ZnO.
Polymers and Polymer Composites
Nanostructured polymers also enhance osteoblast functions. Specifically, Palin et al. [11] transferred the roughness of the aforementioned nanophase and conventional titania to poly-lactic-glycolic acid (PLGA). Similar to titania, increased in vitro osteoblast functions were measured on PLGA cast from nanophase compared to conventional titania. These results suggested that the proactive surface roughness of nanophase materials may be transferable to polymers to promote orthopedic implant efficacy.
Studies in the literature have also shown similar increases in bone cell functions when nanophase (compared to conventional) ceramic particles were incorporated into polymer composites [12] . Specifically, in vitro, up to three times more osteoblasts adhered to PLGA when it contained nanophase compared to conventional titania at the same weight ratio and porosity properties [13] . Moreover, Elias et al. [14] and Price et al. [15] determined significantly greater in vitro osteoblast functions leading to mineral deposition on carbon fibers with nanometer compared to conventional dimensions. Such novel cytocompatibility properties of carbon nanofibers/nanotubes have been translated to polymer composites; specifically, increased in vitro osteoblast adhesion was observed in polyurethane composites with greater weight percentages of nanometer compared to conventional carbon fibers (from 5 -75% weight percent) [15] . In fact, there was a preferred alignment of the osteoblasts and subsequent deposition of calcium containing mineral along the carbon nanofibers present on the surfaces of the polymer [16] . These positive behaviors, combined with the high specific strength of carbon nanofibers/nanotubes, can readily be exploited when using carbon nanofibers/nanotubes polymer composites as reinforcing components in orthopedic applications.
Metals
Metals are not excluded from this list. For example, Webster and Ejiofor [17] provided evidence that such novel properties which promoted bone cell functions on ceramics and polymers are also present for nanophase metals (such as titanium, Ti6Al4V, and CoCr alloys); specifically, in vitro bone cell adhesion was up to three, two, and three times greater on nanophase compared to conventional c.p. titanium, Ti6Al4V, and CoCrMo, respectively. Although in this study, metal nanotographies were created by consolidating nano particles, there are others ways to create nanometer roughness on metal surfaces. Compared to unanodized titanium, Yao et al. [18] demonstrated greater in vitro osteoblast adhesion and mineral deposition on titanium anodized to possess nanometer tubes. The same trends have been observed for anodized aluminum [19] .
In a disease specific study, researchers have reported increased in vitro osteoblast functions on nanophase compared to conventional selenium (a metalloid) [20] . Since selenium has been reported to have certain "anti-cancer" properties, such results highlight the potential use of nanophase selenium in implants for those with bone cancer.
Given the trends of greater osteoblast functions (mostly in vitro but in some cases in vivo) on nanophase compared to conventional ceramics, polymers, carbon fibers, metals, and polymer composites thereof, it is intriguing to ponder why osteoblasts behave so favorably on these materials. This is even more interesting when considering other cell types (specifically, fibroblasts) do not [21] .
Osteoblast Recognition of Nanophase Materials
Surface properties (such as area, charge and morphology) depend on the particulate or fiber size of a material. The increased surface defects (such as at the edge/corner sites) and the high number of surface grain boundaries on nanophase materials have special advantageous properties for interactions with proteins that control osteoblast function. To date, however, the increased surface reactivity of nanomaterials has been utilized almost exclusively for catalytic applications; for example, compared with conventional (> 100 nm average grain size) magnesium oxide (MgO), nanophase (4 nm average grain size) MgO possessed increased number of atoms at the surface, higher surface area, (100 -160 m 2 /g compared to 200-500 m 2 /g, respectively), and less acidic OHgroups (due to a much higher proportion of edge sites for the nanophase MgO to cause delocalization of electrons) leading to the increased adsorption of acidic ions (such as SO 3 -2 and CO 3 -2 ) and destructive adsorption of organophosphorous/chlorocarbons [2, 22] .
The same events may be happening on the aforementioned nanobiomaterials used for orthopedic applications. That is, recent reports have demonstrated that unique special interactions exist between nanophase materials and proteins that mediate bone cell function [23] . Specifically, osteoblasts adhere to select amino acid sequences (such as Arginine-Glycine-Aspartic Acid or RGD) in proteins. Surface properties of an implant will determine whether this amino acid is available or not available for osteoblast adhesion. Since bone cell adhesion on a newly implanted orthopedic surface is imperative for those cells to synthesize bone, initial optimal protein adsorption events are clearly key to implant success. To be more specific, biomaterial surface features (such as surface, roughness, charge, chemistry, wettability, etc.) and the select properties of each protein will influence its adsorption characteristics and ultimately, will affect implant biocompatibility with host tissue.
For nanophase materials, the decrease in surface grain size increases the number of grain boundaries at the surface to alter surface energetic for protein adsorption which, subsequently, changes cell function. In addition, since the dimensions of proteins that mediate cell adhesion are at the nanometer level, a surface with nanometer topography can influence the availability of amino acids for cell adhesion to a greater extent that conventional surfaces which are smooth at the nanoscale. Thus, it is protein interactions that are imperative to controlling subsequent cell function and eventual implant success/failure.
Indeed, literature reports have demonstrated that the cumulative adsorption of proteins from bodily fluids was significantly higher on smaller, nanometer, grain size materials [23] . In particular, the interaction of four proteins -fibronectin, vitronectin, laminin, and collagen -known to enhance osteoblast functions increased greatly on nanophase compared to conventional (micron-sized grains) materials. Further, a novel adaptation of the standard surface-enhanced Raman Scattering (SERS) technique provided evidence of increased unfolding of proteins adsorbed on nanophase versus conventional ceramics [23] . This is important because unfolding of these proteins promotes availability of specific cell-adhesive epitopes that increase bone-cell adhesion and function.
It is now believed that the novel surface properties (nanometer topography, wettability, charge, etc.) of nanophase ceramics are influencing protein interactions to increase new bone formation.
Potential Risks
Since the research on and the use of nanophase materials is still at its infancy, risks to human health and environment must not be overlooked. Many issues relating to safe and healthy fabrication of nanophase ceramics still need to be addressed [24] . For example, small nanoparticles can enter the human body through pores and may accumulate in the cells of the respiratory or other organ systems (when becoming dislodged through wear debris), and the health effects are yet to be largely known. This would happen during commercial-scale processing of the nanoparticles as well as through the use of these materials as implants. There should be a need for continuous monitoring of potential effects of newly designed and fabricated nanomaterials.
As an example, although nanophase materials have increased wear properties, debris may form from articulating components of orthopedic implants when subjected to physiological loading properties [25] . These particles induce bone loss which leads to implant loosening, and sometimes results in clinical failure of bone prostheses (such as hip, elbow, knee, ankle, etc.). In a recent report, however, results of a more well-spread morphology and increased bone cell proliferation in the presence of nanophase wear debris demonstrated less adverse influences on bone and cartilage cell function in comparison to larger conventional ceramic wear particles [26, 27] ; the same has been observed for carbon nanofibers [28] . These findings consistently testify to unprecedented and excellent cytocompatibility of nanophase materials with regenerating bone; criteria critical for the fixation of orthopedic implants so that patients can resume a normal active lifestyle. Of course, if future research determines that free-floating nanoparticles are not safe inside the body, other techniques to create nanometer surface roughness will need to be utilized (such as anodization, chemical etching, photolithography, coating with nanometer self-assembled chemistries, etc. which are already showing promise towards increasing bone growth [29] ).
We would like to note that the scientific developments reported above do not exhaust the current global beehive of research efforts on the biological potentials of nano particulates as implants. It is believed, however, that following the trends of these impressive application properties of the nanomaterials into the orthopedic domain, there exists a bright future for therapies and treatments through bone prosthetic implantation. Recent developments in modifying existing conventional materials to possess nanoscale features may increase new bone synthesis to offer exciting promising alternatives to bone tissue engineering. This is a much easier route to exploiting the beneficial properties of nanostructured materials as nano biomedical implants than creating new chemistries that have not been, yet, recommended for inside-the-body use.
